Dutch Society for Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2001, Vol 52, Num 5, pp 615P-627P, issn 0306-5251Conference Proceedings

Dutch Society for Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2002, Vol 53, Num 5, pp 543P-559P, issn 0306-5251Conference Proceedings

Dutch Society for Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2000, Vol 50, Num 5, pp 485P-499P, issn 0306-5251Conference Proceedings

Dutch Society of Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2010, Vol 70, Num 6, pp 918-931, issn 0306-5251, 14 p.Conference Paper

Dutch Society for Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2000, Vol 49, Num 4, pp 383P-396P, issn 0306-5251Conference Proceedings

Dutch Society for Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 1999, Vol 47, Num 4, pp 463P-477P, issn 0306-5251Conference Proceedings

The Dutch Society for Clinical Pharmacology and Biopharmacy. MeetingBritish journal of clinical pharmacology. 1999, Vol 48, Num 5, pp 766P-783P, issn 0306-5251Conference Proceedings

Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy MeetingBritish journal of clinical pharmacology. 2011, Vol 72, Num 5, pp 843-863, issn 0306-5251, 21 p.Conference Paper

Dutch Society of Clinical Pharmacology and Biopharmacy MeetingBritish journal of clinical pharmacology. 2008, Vol 65, Num 2, pp 283-297, issn 0306-5251, 14 p.Conference Paper

The Dutch Society of Clinical Pharmacology and Biopharmacy MeetingBritish journal of clinical pharmacology. 2006, Vol 62, Num 6, pp 719-739, issn 0306-5251, 20 p.Conference Paper

Dutch society of clinical pharmacology and biopharmacy meetingBritish journal of clinical pharmacology. 2007, Vol 63, Num 4, pp 503-508, issn 0306-5251, 5 p.Conference Paper

Lead poisoning: case studiesGORDON, J. N; TAYLOR, A; BENNETT, P. N et al.British journal of clinical pharmacology. 2002, Vol 53, Num 5, pp 451-458, issn 0306-5251Conference Paper

Therapeutic drug monitoring of psychotropic medicationsMITCHELL, P. B.British journal of clinical pharmacology. 2000, Vol 49, Num 4, pp 303-312, issn 0306-5251Conference Paper

Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy Meeting of April 2011British journal of clinical pharmacology. 2012, Vol 73, Num 2, pp 314-321, issn 0306-5251, 8 p.Conference Paper

Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy Meeting of October 2009British journal of clinical pharmacology. 2010, Vol 69, Num 6, pp 705-714, issn 0306-5251, 10 p.Conference Paper

Population pharmacokinetics and pharmacodynamics of oral etoposideTOFFOLI, Giuseppe; CORONA, Giuseppe; SORIO, Roberto et al.British journal of clinical pharmacology. 2001, Vol 52, Num 5, pp 511-519, issn 0306-5251Conference Paper

Paracetamol, alcohol and the liverPRESCOTT, L. F.British journal of clinical pharmacology. 2000, Vol 49, Num 4, pp 291-301, issn 0306-5251Conference Paper

Design issues for drug epidemiologyMCMAHON, Alex D; MACDONALD, Tom M.British journal of clinical pharmacology. 2000, Vol 50, Num 5, pp 419-425, issn 0306-5251Conference Paper

Flow-mediated dilatationRAITAKARI, Olli T; CELERMAJER, David S.British journal of clinical pharmacology. 2000, Vol 50, Num 5, pp 397-404, issn 0306-5251Conference Paper

Effect of alosetron on theophylline pharmacokineticsKOCH, K. M; RICCI, B. M; HEDAYETULLAH, N. S et al.British journal of clinical pharmacology. 2001, Vol 52, Num 5, pp 596-600, issn 0306-5251Conference Paper

Therapeutic drug monitoring of immunosuppressant drugsJOHNSTON, A; HOLT, D. W.British journal of clinical pharmacology. 1999, Vol 47, Num 4, pp 339-350, issn 0306-5251Conference Paper

Chronopharmacology of intravenous and oral modified release verapamilDILGER, K; ECKHARDT, K; HOFMANN, U et al.British journal of clinical pharmacology. 1999, Vol 47, Num 4, pp 413-419, issn 0306-5251Conference Paper

Determinants of signal selection in a spontaneous reporting system for adverse drug reactionsVAN PUIJENBROEK, Eugène P; VAN GROOTHEEST, Kees; DIEMONT, Willem L et al.British journal of clinical pharmacology. 2001, Vol 52, Num 5, pp 579-586, issn 0306-5251Conference Paper

An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2EI) and midazolam (CYP3A)PALMER, J. L; SCOTT, R. J; GIBSON, A et al.British journal of clinical pharmacology. 2001, Vol 52, Num 5, pp 555-561, issn 0306-5251Conference Paper

Candidate gene case-control association studies: advantages and potential pitfallsDALY, Ann K; DAY, Christopher P.British journal of clinical pharmacology. 2001, Vol 52, Num 5, pp 489-499, issn 0306-5251Conference Paper